1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021, 42(5):373-498.
2. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP et al: Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 2019, 139(10):e56-e528.
3. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021, 42(5):373-498.
4. Van Wagoner DR: Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008, 52(4):306-313.
5. Harada M, Van Wagoner DR, Nattel S: Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 2015, 79(3):495-502.
6. Lin Y, Peng Y, Chen Y, Li S, Huang X, Zhang H et al: Association of lymphocyte to monocyte ratio and risk of in-hospital mortality in patients with acute type A aortic dissection. Biomark Med 2019, 13(15):1263-1272.
7. Wang Q, Ma J, Jiang Z, Wu F, Ping J, Ming L: Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction. Medicine (Baltimore) 2017, 96(34):e7897.
8. Silva N, Bettencourt P, Guimarães JT: The lymphocyte-to-monocyte ratio: an added value for death prediction in heart failure. Nutr Metab Cardiovasc Dis 2015, 25(11):1033-1040.
9. Ertem AG, Yayla C, Acar B, Kirbas O, Unal S, Uzel Sener M et al: Relation between lymphocyte to monocyte ratio and short-term mortality in patients with acute pulmonary embolism. Clin Respir J 2018, 12(2):580-586.
10. AltinbaŞ Ö, Demiryürek Ş, Işık M, Tanyeli Ö, Dereli Y, Görmüş N: Predictive Value of Neutrophil-to-Lymphocyte, Aspartate-to-Alanine Aminotransferase, Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratios in Severity and Side of Carotid Artery Stenosis: Are Those Significant? Heart Surg Forum 2021, 24(1):E072-e078.
11. Chen MC, Chang JP, Liu WH, Yang CH, Chen YL, Tsai TH et al: Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol 2008, 102(7):861-865.
12. Chimenti C, Russo MA, Carpi A, Frustaci A: Histological substrate of human atrial fibrillation. Biomed Pharmacother 2010, 64(3):177-183.
13. Hohmann C, Pfister R, Mollenhauer M, Adler C, Kozlowski J, Wodarz A et al: Inflammatory cell infiltration in left atrial appendageal tissues of patients with atrial fibrillation and sinus rhythm. Sci Rep 2020, 10(1):1685.
14. Liu L, Lee J, Fu G, Liu X, Wang H, Zhang Z et al: Activation of peripheral blood CD3(+) T-lymphocytes in patients with atrial fibrillation. Int Heart J 2012, 53(4):221-224.
15. Shantsila E, Lip GY: The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost 2009, 102(5):916-924.
16. Pfluecke C, Tarnowski D, Plichta L, Berndt K, Schumacher P, Ulbrich S et al: Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation. Clin Res Cardiol 2016, 105(4):314-322.
17. Yu Y, Wang J, Wang Q, Wang J, Min J, Wang S et al: Admission oxygen saturation and all-cause in-hospital mortality in acute myocardial infarction patients: data from the MIMIC-III database. Ann Transl Med 2020, 8(21):1371.
18. Yao RQ, Jin X, Wang GW, Yu Y, Wu GS, Zhu YB et al: A Machine Learning-Based Prediction of Hospital Mortality in Patients With Postoperative Sepsis. Front Med (Lausanne) 2020, 7:445.
19. Yu Y, Yu J, Yao R, Wang P, Zhang Y, Xiao J et al: Admission Serum Ionized and Total Calcium as New Predictors of Mortality in Patients with Cardiogenic Shock. Biomed Res Int 2021, 2021:6612276.
20. Johnson AE, Pollard TJ, Shen L, Lehman LW, Feng M, Ghassemi M et al: MIMIC-III, a freely accessible critical care database. Sci Data 2016, 3:160035.
21. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370(9596):1453-1457.
22. Camp RL, Dolled-Filhart M, Rimm DL: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004, 10(21):7252-7259.
23. White IR, Royston P, Wood AM: Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011, 30(4):377-399.
24. D'Agostino RB, Jr.: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998, 17(19):2265-2281.
25. Austin PC: An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res 2011, 46(3):399-424.
26. Austin PC: Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011, 10(2):150-161.
27. Zhou Z, Liang M, Wu H, Huang S, Weng R, Hou J et al: Preoperative Lymphocyte-to-Monocyte Ratio as a Prognostic Predictor of Long-Term Mortality in Cardiac Surgery Patients: A Propensity Score Matching Analysis. Front Cardiovasc Med 2021, 8:639890.
28. Canpolat U, Aytemir K, Yorgun H, Şahiner L, Kaya EB, Kabakçı G et al: Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol 2013, 112(4):513-519.
29. Shao Q, Chen K, Rha SW, Lim HE, Li G, Liu T: Usefulness of Neutrophil/Lymphocyte Ratio as a Predictor of Atrial Fibrillation: A Meta-analysis. Arch Med Res 2015, 46(3):199-206.
30. Acet H, Ertaş F, Akıl MA, Oylumlu M, Polat N, Yıldız A et al: New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Int J Cardiovasc Imaging 2014, 30(1):81-89.
31. Gungor H, Babu AS, Zencir C, Akpek M, Selvi M, Erkan MH et al: Association of Preoperative Platelet-to-Lymphocyte Ratio with Atrial Fibrillation after Coronary Artery Bypass Graft Surgery. Med Princ Pract 2017, 26(2):164-168.
32. Şaşkın H, Düzyol Ç, Özcan KS, Aksoy R, Idiz M: Preoperative Platelet to Lymphocyte Ratio Is Associated with Early Morbidity and Mortality after Coronary Artery Bypass Grafting. Heart Surg Forum 2015, 18(6):E255-262.
33. Zhang H, Li J, Chen X, Wu N, Xie W, Tang H et al: Association of Systemic Inflammation Score With Atrial Fibrillation: A Case-Control Study With Propensity Score Matching. Heart Lung Circ 2018, 27(4):489-496.
34. Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E: Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013, 62(17):1541-1551.
35. Núñez J, Núñez E, Bodí V, Sanchis J, Mainar L, Miñana G et al: Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coron Artery Dis 2010, 21(1):1-7.
36. Olesen OJ, Vinding NE, Østergaard L, Butt JH, Gislason GH, Torp-Pedersen C et al: C-reactive protein after coronary artery bypass graft surgery and its relationship with postoperative atrial fibrillation. Europace 2020, 22(8):1182-1188.
37. Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S: Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011, 121(8):2955-2968.
38. Van Wagoner DR, Chung MK: Inflammation, Inflammasome Activation, and Atrial Fibrillation. Circulation 2018, 138(20):2243-2246.
39. Smorodinova N, Bláha M, Melenovský V, Rozsívalová K, Přidal J, Ďurišová M et al: Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm. PLoS One 2017, 12(2):e0172691.
40. Yamashita T, Sekiguchi A, Iwasaki YK, Date T, Sagara K, Tanabe H et al: Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 2010, 74(2):262-270.
41. Sulzgruber P, Thaler B, Koller L, Baumgartner J, Pilz A, Steininger M et al: CD4(+)CD28(null) T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery. Sci Rep 2018, 8(1):9624.
42. Sulzgruber P, Koller L, Winter MP, Richter B, Blum S, Korpak M et al: The impact of CD4(+)CD28(null) T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure. Thromb Haemost 2017, 117(2):349-356.
43. Vaduganathan M, Ambrosy AP, Greene SJ, Mentz RJ, Subacius HP, Maggioni AP et al: Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail 2012, 5(6):750-758.
44. Villois P, Grimaldi D, Spadaro S, Shinotsuka CR, Fontana V, Scolletta S et al: Lymphopaenia in cardiac arrest patients. Ann Intensive Care 2017, 7(1):85.
45. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP: Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 1997, 79(6):812-814.
46. Deng H, Xue YM, Zhan XZ, Liao HT, Guo HM, Wu SL: Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation. Chin Med J (Engl) 2011, 124(13):1976-1982.
47. Bosch NA, Cimini J, Walkey AJ: Atrial Fibrillation in the ICU. Chest 2018, 154(6):1424-1434.
48. Moss TJ, Calland JF, Enfield KB, Gomez-Manjarres DC, Ruminski C, DiMarco JP et al: New-Onset Atrial Fibrillation in the Critically Ill. Crit Care Med 2017, 45(5):790-797.